Comments*

 
  • Events 

    October 18 - 22, 2015

    Tenth Cooley's Anemia Symposium

    Keynote Speakers: Maria Domenica Cappellini (University of Milan) and Stuart H. Orkin (Boston Children's Hospital and Dana-Farber Cancer Institute)
    Speakers: Emanuele Angelucci (Cancer Hospital "Armando Businco," Cagliari), Jodie L. Babitt (Massachusetts General Hospital), Jonathan M. Barasch (Columbia University), Daniel E. Bauer (Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School), Sunil Bhandari (Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School), Caterina Borgna-Pignatti (University of Ferrara), Farid Boulad (Memorial Sloan-Kettering Cancer Center), Marina Cavazzana-Calvo (Hospital Necker, University Paris Descartes), David H.K. Chui (Boston University School of Medicine), Thomas D. Coates (Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine), Ann Dean (National Institutes of Health), David Dinan (Nemours Children’s Hospital), Alexander (Hal) Drakesmith (Radcliffe Department of Medicine, University of Oxford), Kathleen Durst (Cooley's Anemia Foundation), Giuliana Ferrari (San Raffaele-Telethon Institute for Gene Therapy), Steven Flamm (Northwestern Medical Center), Mark D. Fleming (Boston Children's Hospital), Ellen B. Fung (UCSF Benioff Children's Hospital Oakland), Andrea Giusti (Galliera Hospital), Olivier Hermine (Hospital Necker, University Paris Descartes), Doug Higgs (University of Oxford), Eldad Arie Hod (Columbia University), Janet L. Kwiatowski (The Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania), Ashutosh (Ash) Lal (University of California San Francisco Benioff Children’s Hospital Oakland), Roberto Machado (University of Illinois College of Medicine), Punam Malik (Cincinnati Children’s Hospital), Jeffery L. Miller (National Institute of Diabetes and Digestive and Kidney Diseases), David G. Nathan (Dana-Farber Cancer Institute), Elizabeth (Ella) Nemeth (University of California, Los Angeles), Ellis Neufeld (Boston Children's Hospital), Arthur Nienhuis (St. Jude Children's Research Hospital), Dudley Pennell (Imperial College London), Antonio Piga (Torino University), John Porter (University College London Hospitals), Stefano Rivella (Children's Hospital of Philadelphia), Thomas M. Ryan (The University of Alabama at Birmingham), Vijay Sankaran (Boston Children's Hospital and Dana-Farber Cancer Institute), Shalini Shenoy (St. Louis Children's Hospital), Ali Taher (American University of Beirut Medical Center), Swee Lay Thein, John F. Tisdale (National Heart, Lung, and Blood Institute), Suzy V. Torti (University of Connecticut Health Center), Tim M. Townes (The University of Alabama at Birmingham), Marsha J. Treadwell (Children's Hospital Oakland), Vip Viprakasit (Siriraj Hospital, Mahidol University), John C. Wood (Children's Hospital Los Angeles)

    Global experts explore the biology of globin gene regulation and fetal hemoglobin induction; stem cell transplant, gene therapy strategies, and gene editing; and clinical issues in thalassemia treatment and imaging.

  • Past Events

    Thursday, June 11, 2015 | 8:45 AM - 5:15 PM

    Learning from Cancer to Advance Neurodegeneration Drug Discovery and Development

    Keynote Speaker: Jane A. Driver (Brigham and Women's Hospital)
    Speakers: Kurt Brunden (University of Pennsylvania), Stuart Calderwood (Harvard Medical School), Gary Landreth (Case Western Reserve University), Tamara Maes, PhD (Oryzon Genomics S.A.), David M. Roy (Memorial Sloan Kettering Cancer Center), Stephen Strittmatter (Yale University School of Medicine), Li Huei Tsai (Massachusetts Institute of Technology), Raymond Scott Turner (Georgetown University), Claes Wahlestedt (University of Miami Miller School of Medicine), Hui Zheng (Baylor College of Medicine)

    Does having cancer decrease your risk of developing neurodegenerative diseases? Why do many cancer drug targets overlap with targets for neurodegenerative diseases? This meeting will address these questions to help advance therapeutic development.

    Tuesday, February 24, 2015 | 8:30 AM - 4:30 PM

    Harnessing the Potential of Genome Editing for Drug Discovery: Translational Frontiers of in vitro and in vivo Applications

    Speakers: Chad Cowan (Harvard University), James Inglese (National Center for Advancing Translational Sciences, NIH), J. Keith Joung (Massachusetts General Hospital), Randall Platt (Massachusetts Institute of Technology), Yi Yang (Novartis Institutes for Biomedical Research), Lei (Stanley) Qi (University of California San Francisco)

    The emergence of genome editing technologies such as TALEN and CRISPR/Cas9 are revolutionizing our ability to rapidly engineer mammalian systems. This symposium explores the frontiers of genome editing and potential to aid therapeutic development.

    Thursday, October 24, 2013 | 8:30 AM - 7:00 PM

    Seventh Annual Parkinson's Disease Therapeutics Conference

    Speakers: Charles H. Adler (Mayo Clinic Arizona / Arizona Parkinson's Disease Consortium), Raymond Bartus (RTBioconsultants, Inc.), Donald E. Frail (AstraZeneca PLC), Reina Fuji, VMD (Genentech Inc.), Kimberley S. Gannon (NeuroPhage Pharmaceuticals, Inc.), Kenneth Marek (Institute for Neurodegenerative Disorders), Mary Maral Mouradian (Rutgers - Robert Wood Johnson Medical School), Adrian Newman-Tancredi (Neurolixis, Inc.), Michael A. Schwarzschild (Massachusetts General Hospital), Eric Siemers (Eli Lilly and Company), Peggy Taylor (Covance Inc.)

    Explore emerging basic and translational research that impacts our understanding of Parkinson's Disease and its treatment.

    Monday, June 24, 2013 | 10:30 AM - 3:00 PM

    Translating Immunology Discoveries into Therapies: Inaugural Ross Prize in Molecular Medicine

    Speakers: Yasmine Belkaid (National Institute of Allergy and Infectious Diseases, NIH), Dan R. Littman (New York University School of Medicine), Alexander Rudensky (Memorial Sloan-Kettering Cancer Center)

    The Ross Prize, established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine, is awarded to an investigator producing innovative, paradigm-shifting research worthy of significant attention in molecular medicine.